Kurin Inc.

Kurin Inc.:

Description: Kurin® is a privately held, certified minority-owned business dedicated to engineering better healthcare through innovative, cost-effective, clinician-approved technologies. Building on the successful invention, clinical adoption, and corporate acquisition of Curos™ disinfecting port protectors, Kurin is focusing its depth of experience in medical device engineering, marketing, sales, and service to tackle the persistent and costly fallout of false positive blood cultures. With agile development capabilities and intense customer focus, we have seen the Kurin Lock® with Flash Technology quickly gain caregiver acceptance, sideline skin contaminants during blood culture collection, and become the blood culture collection standard of care in hospitals.

Founded: 2015

Industries: Health Care

Headquarter: United States

Last Investment: $2.32M Venture Round investment at 06 October 2016

Last Investment Investors: Baker & Eastlack Ventures

Kurin Inc. is reshaping the standard of care in blood culture collection with its Kurin Lock® with Flash Technology. The company, founded in 2015, has received a significant investment of $2.32M in a Venture Round from Baker & Eastlack Ventures. With an emphasis on innovative and cost-effective healthcare technologies, Kurin aims to address the costly challenges of false-positive blood cultures. The company's success in gaining caregiver acceptance and becoming the standard of care in hospitals showcases its potential to make a lasting impact in the health care industry.